Literature DB >> 31577937

A review of the ethnopharmacology, phytochemistry, pharmacology, and quality control of Scutellaria barbata D. Don.

Liang Wang1, Wei Chen2, Mingming Li2, Feng Zhang2, Kaixian Chen1, Wansheng Chen3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Scutellaria barbata D. Don (S. barbata) is a well-known perennial herb that is used in traditional Chinese and Korean medicine. In China, it is known as Ban Zhi Lian, while in Korea, it is known as Banjiryun. In the Traditional Chinese Medicine (TCM) system, S. barbata has heat-clearing and detoxifying properties (Qingre Jiedu in Chinese). AIM OF THE REVIEW: To provide a systematic review on current multifaceted understanding of S. barbata, with particular emphasis on the correlation between its traditional applications and pharmacological activities.
MATERIALS AND METHODS: All available S. barbata-related information from internet databases, including PubMed, Science Direct, Elsevier, China National Knowledge Internet, and Google Scholar (up to October 2018) were searched. Additional information was gathered from classical books on Chinese Herbals, Chinese Pharmacopoeia, and so on.
RESULTS: In the TCM system, S. barbata is mainly prescribed for its heat-clearing and detoxifying effects. More than 203 compounds have been isolated and identified from this herb, with neo-clerodane diterpenoids and flavonoids as the main compounds. Most neo-clerodanes have been demonstrated to have cytotoxic effects against different cancer cell types in vitro. The S. barbata extracts exhibited anti-inflammatory, anti-microbial, antitumor, and other pharmacological activities. To add, flavonoids, including wogonin, baicalein, apigenin, naringenin, and scutellarin, were identified as the key to quality control.
CONCLUSIONS: The heat-clearing effects of S. barbata could be attributed to its anti-inflammatory and hepatoprotective activities, whereas its detoxifying effects might be due to the anti-microbial functions of neo-clerodane diterpenoids and flavones. S. barbata may display anti-tumor effects and through active ingredient analysis, neo-clerodane diterpenoids are suggested to be its representative compounds. Overall, many pre-clinical studies have been conducted but very little concrete evidences are available on its specific effects, which are of therapeutic relevance.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Pharmacology; Phytochemistry; Quality control; Scutellaria barbata D. don; Traditional use

Mesh:

Substances:

Year:  2019        PMID: 31577937     DOI: 10.1016/j.jep.2019.112260

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  11 in total

1.  Molecular Targets and Mechanisms of Hedyotis diffusa-Scutellaria barbata Herb Pair for the Treatment of Colorectal Cancer Based on Network Pharmacology and Molecular Docking.

Authors:  Zhenpeng Yang; Shuai Lu; Huazhen Tang; Jinxiu Qu; Bing Wang; Yuying Wang; Guofeng Pan; Benqiang Rao
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-06       Impact factor: 2.650

2.  Investigating the Mechanism of Scutellariae barbata Herba in the Treatment of Colorectal Cancer by Network Pharmacology and Molecular Docking.

Authors:  Xiangjun Qi; Hongbin Xu; Peng Zhang; Guoming Chen; Zhiqiang Chen; Caishan Fang; Lizhu Lin
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-02       Impact factor: 2.629

3.  Molecular Assessment of Scutellaria barbata D. Don in the Treatment of Nasopharyngeal Carcinoma Based on Network Pharmacology and Experimental Verification.

Authors:  Hongjian Shi; Jie Liu; Jingying Fan; Lan He; Xianwen Wang; Faqing Tang; Daofa Tian; Yingchun He
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-07       Impact factor: 2.629

4.  Network pharmacology-based strategy to investigate the active ingredients and molecular mechanisms of Scutellaria Barbata D. Don against radiation pneumonitis.

Authors:  Ping-Yi Sun; Ai-Shuai Wang; Zhen-Fei Zhang; Yan-Li Zhang; Xin Zheng
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

5.  Anti-Photoaging Activity of Scutellaria barbata D. Don (Family Lamiaceae) on Ultraviolet B-Irradiated NIH-3T3 Skin Fibroblast and SKH-1 Hairless Mouse.

Authors:  Jong Min Jung; Jong Kyu Choi; Oh Yun Kwon; Seung Ho Lee
Journal:  Molecules       Date:  2022-06-13       Impact factor: 4.927

6.  Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.

Authors:  Sheng-Teng Huang; Yeh Chen; Wei-Chao Chang; Hsiao-Fan Chen; Hsiang-Chun Lai; Yu-Chun Lin; Wei-Jan Wang; Yu-Chuan Wang; Chia-Shin Yang; Shao-Chun Wang; Mien-Chie Hung
Journal:  Viruses       Date:  2021-05-02       Impact factor: 5.048

7.  Green synthesis of silver nanoparticles from aqueous extract of Scutellaria barbata and coating on the cotton fabric for antimicrobial applications and wound healing activity in fibroblast cells (L929).

Authors:  Vishnu Priya Veeraraghavan; Nanthini Devi Periadurai; Thiruventhan Karunakaran; Sardar Hussain; Krishna Mohan Surapaneni; Xinsheng Jiao
Journal:  Saudi J Biol Sci       Date:  2021-05-08       Impact factor: 4.219

8.  Exploring the Mechanism of Scutellaria baicalensis Georgi Efficacy against Oral Squamous Cell Carcinoma Based on Network Pharmacology and Molecular Docking Analysis.

Authors:  Fanfan Hou; Yang Liu; YaHsin Cheng; Ni Zhang; Wenpeng Yan; Fang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-13       Impact factor: 2.629

9.  Erzhu Jiedu decoction ameliorates liver precancerous lesions in a rat model of liver cancer.

Authors:  Yang Cheng; Tianyang Chen; Jianjie Chen
Journal:  J Cancer       Date:  2020-10-22       Impact factor: 4.207

10.  Effects of Traditional Chinese Medicine for Vaginal Lavage Combined with Psychological Intervention in Postoperative Patients with Cervical Cancer.

Authors:  Rufen Ma; Ruixiang Yu; Yuchao Yuan; Baofeng Ren; Yuan Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.